Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Richard Kostrzewa

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Chemicals & Drugs

Anatomy

Disorders

Yawning

Activities & Behaviors

Physiology

Pregnancy

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
52
Brus, Ryszard
30
Nowak, Przemyslaw
10
Perry, Kenneth
10
Kostrzewa, John
8
Bortel, Aleksandra
7
Szczerbak, Grazyna
6
Szkilnik, Ryszard
6
Dabrowska, Joanna
5
Josko, Jadwiga
5
Kwiecinski, Adam
5
Segura-Aguilar, Juan
4
Labus, Lukasz
4
Kostrzewa, Rose
4
Biedka, Izabela
3
Brown, Russell

Sign-in to see all Coauthors

Publications

TOP 3
Nowak Przemyslaw; Noras Lukasz; Jochem Jerzy; Szkilnik Ryszard; Brus Halina; Körossy Eva; Drab Jacek; Kostrzewa Richard M; Brus Ryszard
Histaminergic activity in a rodent model of Parkinson's disease.
Nowak Przemyslaw; Nitka Dariusz; Kwiecinski Adam; Josko Jadwiga; Drab Jacek; Pojda-Wilczek Dorota; Kasperski Jacek; Kostrzewa Richard M; Brus Ryszard
Neonatal co-lesion by DSP-4 and 5,7-DHT produces adulthood behavioral sensitization to dopamine D(2) receptor agonists.
Kostrzewa Richard M
Evolution of neurotoxins: from research modalities to clinical realities.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Richard Kostrzewa (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Nowak Przemyslaw; Noras Lukasz; Jochem Jerzy; Szkilnik Ryszard; Brus Halina; Körossy Eva; Drab Jacek; Kostrzewa Richard M; Brus Ryszard
Histaminergic activity in a rodent model of Parkinson's disease.
Neurotoxicity research 2009;15(3):246-51.
2009: Nowak Przemyslaw; Nitka Dariusz; Kwiecinski Adam; Josko Jadwiga; Drab Jacek; Pojda-Wilczek Dorota; Kasperski Jacek; Kostrzewa Richard M; Brus Ryszard
Neonatal co-lesion by DSP-4 and 5,7-DHT produces adulthood behavioral sensitization to dopamine D(2) receptor agonists.
Pharmacological reports : PR 2009;61(2):311-8.
2009: Kostrzewa Richard M
Evolution of neurotoxins: from research modalities to clinical realities.
Current protocols in neuroscience / editorial board, Jacqueline N. Crawley ... [et al.] 2009;Chapter 1():Unit 1.18.
2008: Nowak Przemyslaw; Szczerbak Grazyna; Nitka Dariusz; Kostrzewa Richard M; Josko Jadwiga; Brus Ryszard
Cortical dopaminergic neurotransmission in rats intoxicated with lead during pregnancy. Nitric oxide and hydroxyl radicals formation involvement.
Neurotoxicology and teratology 2008;30(5):428-32.
2008: Bortel Aleksandra; Slomian Lucyna; Nitka Dariusz; Swierszcz Michal; Jaksz Mirella; Adamus-Sitkiewicz Beata; Nowak Przemyslaw; Josko Jadwiga; Kostrzewa Richard M; Brus Ryszard
Neonatal N-(-2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) treatment modifies the vulnerability to phenobarbital- and ethanol-evoked sedative-hypnotic effects in adult rats.
Pharmacological reports : PR 2008;60(3):331-8.
2008: Nowak Przemyslaw; Bortel Aleksandra; Dabrowska Joanna; Biedka Izabela; Slomian Grzegorz; Roczniak Wojciech; Kostrzewa Richard M; Brus Ryszard
Histamine H(3) receptor ligands modulate L-dopa-evoked behavioral responses and L-dopa derived extracellular dopamine in dopamine-denervated rat striatum.
Neurotoxicity research 2008;13(3-4):231-40.
2008: Paris Irmgard; Lozano Jorge; Cardenas Sergio; Perez-Pastene Carolina; Saud Katherine; Fuentes Patricio; Caviedes Pablo; Dagnino-Subiabre Alexies; Raisman-Vozari Rita; Shimahara Takeshi; Kostrzewa John P; Chi David; Kostrzewa Richard M; Caviedes Raul; Segura-Aguilar Juan
The catecholaminergic RCSN-3 cell line: a model to study dopamine metabolism.
Neurotoxicity research 2008;13(3-4):221-30.
2008: Nowak Przemyslaw; Jochem Jerzy; Zwirska-Korczala Krystyna; Josko Jadwiga; Noras Lukasz; Kostrzewa Richard M; Brus Ryszard
Ontogenetic noradrenergic lesion alters histaminergic activity in adult rats.
Neurotoxicity research 2008;13(2):79-83.
2008: Nowak Przemyslaw; Szczerbak Grazyna; Nitka Dariusz; Kostrzewa Richard M; Sitkiewicz Tomasz; Brus Ryszard
Effect of prenatal lead exposure on nigrostriatal neurotransmission and hydroxyl radical formation in rat neostriatum: dopaminergic-nitrergic interaction.
Toxicology 2008;246(1):83-9.
2008: Kostrzewa R M; Kostrzewa J P; Kostrzewa R A; Nowak P; Brus R
Pharmacological models of ADHD.
Journal of neural transmission (Vienna, Austria : 1996) 2008;115(2):287-98.
2007: Kostrzewa Richard M; Segura-Aguilar Juan
Botulinum neurotoxin: evolution from poison, to research tool--onto medicinal therapeutic and future pharmaceutical panacea.
Neurotoxicity research 2007;12(4):275-90.
2007: Xu Xingshun; Chua Chu C; Kong Jiming; Kostrzewa Richard M; Kumaraguru Udayasankar; Hamdy Ronald C; Chua Balvin H L
Necrostatin-1 protects against glutamate-induced glutathione depletion and caspase-independent cell death in HT-22 cells.
Journal of neurochemistry 2007;103(5):2004-14.
2007: Szczerbak Grazyna; Nowak Przemyslaw; Kostrzewa Richard M; Brus Ryszard
Maternal lead exposure produces long-term enhancement of dopaminergic reactivity in rat offspring.
Neurochemical research 2007;32(10):1791-8.
2007: Nowak Przemyslaw; Swoboda Marek; Szkilnik Ryszard; Josko Jadwiga; Noras Lukasz; Kwiecinski Adam; Sawczuk Katarzyna; Herba Ewa; Pojda-Wilczek Dorota; Kostrzewa Richard M; Brus Ryszard
Nitric oxide modulates the amphetamine effect on [3H]glucose uptake in the brain of rats prenatally exposed to lead.
Pharmacological reports : PR 2007;59(5):601-5.
2007: Kostrzewa Richard M
The blood-brain barrier for catecholamines - revisited.
Neurotoxicity research 2007;11(3-4):261-71.
2007: Nowak Przemyslaw; Bortel Aleksandra; Dabrowska Joanna; Oswiecimska Joanna; Drosik Marzena; Kwiecinski Adam; Opara Józef; Kostrzewa Richard M; Brus Ryszard
Amphetamine and mCPP effects on dopamine and serotonin striatal in vivo microdialysates in an animal model of hyperactivity.
Neurotoxicity research 2007;11(2):131-44.
2007: Kostrzewa Richard M; Huang Nuo-Yu; Kostrzewa John P; Nowak Przemyslaw; Brus Ryszard
Modeling tardive dyskinesia: predictive 5-HT2C receptor antagonist treatment.
Neurotoxicity research 2007;11(1):41-50.
2006: Nowak P; Szczerbak G; Biedka I; Drosik M; Kostrzewa R M; Brus R
Effect of ketanserin and amphetamine on nigrostriatal neurotransmission and reactive oxygen species in Parkinsonian rats. In vivo microdialysis study.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 2006;57(4):583-97.
2006: Segura-Aguilar Juan; Kostrzewa Richard M
Neurotoxins and neurotoxicity mechanisms. An overview.
Neurotoxicity research 2006;10(3-4):263-87.
2006: Nowak Przemyslaw; Dabrowska Joanna; Bortel Aleksandra; Biedka Izabela; Szczerbak Grazyna; Slomian Grzegorz; Kostrzewa Richard M; Brus Ryszard
Histamine H3 receptor agonist- and antagonist-evoked vacuous chewing movements in 6-OHDA-lesioned rats occurs in an absence of change in microdialysate dopamine levels.
European journal of pharmacology 2006;552(1-3):46-54.
2006: Nowak Przemyslaw; Szczerbak Grazyna; Dabrowska Joanna; Bortel Aleksandra; Biedka Izabela; Kostrzewa Richard M
[Molecular mechanisms of levodopa action in animal models of Parkinson's disease]
Neurologia i neurochirurgia polska 2006;40(6):517-25.
2006: Thacker Stephanie K; Perna Marla K; Ward Jeffery J; Schaefer Tori L; Williams Michael T; Kostrzewa Richard M; Brown Russell W
The effects of adulthood olanzapine treatment on cognitive performance and neurotrophic factor content in male and female rats neonatally treated with quinpirole.
The European journal of neuroscience 2006;24(7):2075-83.
2006: Nowak Przemyslaw; Dabrowska Joanna; Bortel Aleksandra; Izabela Biedka; Kostrzewa Richard M; Brus Ryszard
Prenatal cadmium and ethanol increase amphetamine-evoked dopamine release in rat striatum.
Neurotoxicology and teratology 2006;28(5):563-72.
2006: Nowak Przemyslaw; Zagzil Tomasz; Konecki Janusz; Szczerbak Grazyna; Szkilnik Ryszard; Niwinski Janusz; Gorzalek Jaroslaw; Kostrzewa Richard M; Brus Ryszard
Trimetazidine increases [3H]glucose uptake in rat brain.
Pharmacological reports : PR 2006;58(4):559-61.
2006: Nowak Przemyslaw; Labus Lukasz; Kostrzewa Richard M; Brus Ryszard
DSP-4 prevents dopamine receptor priming by quinpirole.
Pharmacology, biochemistry, and behavior 2006;84(1):3-7.
2006: Kostrzewa R M; Kostrzewa J P; Brus R; Kostrzewa R A; Nowak P
Proposed animal model of severe Parkinson's disease: neonatal 6-hydroxydopamine lesion of dopaminergic innervation of striatum.
Journal of neural transmission. Supplementum 2006;(70):277-9.
2005: Nowak P; Kostrzewa R M; Kwiecinski A; Bortel A; Labus L; Brus R
Neurotoxic action of 6-hydroxydopamine on the nigrostriatal dopaminergic pathway in rats sensitized with D-amphetamine.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 2005;56(2):325-33.
2005: Kostrzewa Richard M
II Neurotoxicity Society Meeting. Mechanisms for neurodegenerative disorders.
IDrugs : the investigational drugs journal 2005;8(6):469-71.
2005: Kuballa Grzegorz; Nowak Przemyslaw; Labus Lukasz; Bortel Aleksandra; Dabrowska Joanna; Swoboda Marek; Kwiecinski Adam; Kostrzewa Richard M; Brus Ryszard
Central effects of nafadotride, a dopamine D3 receptor antagonist, in rats. Comparison with haloperidol and clozapine.
Pharmacological reports : PR 2005;57(2):161-9.
2005: Kostrzewa R M; Nowak P; Kostrzewa J P; Kostrzewa R A; Brus R
Peculiarities of L: -DOPA treatment of Parkinson's disease.
Amino acids 2005;28(2):157-64.
2004: Sieron Aleksander; Labus Lukasz; Nowak Przemyslaw; Cieslar Grzegorz; Brus Halina; Durczok Artur; Zagzil Tomasz; Kostrzewa Richard M; Brus Ryszard
Alternating extremely low frequency magnetic field increases turnover of dopamine and serotonin in rat frontal cortex.
Bioelectromagnetics 2004;25(6):426-30.
2004: Brown Russell W; Thompson Kenyatta D; Thompson Kimberly N; Ward J Jeffrey; Thacker Stephanie K; Williams Michael T; Kostrzewa Richard M
Adulthood nicotine treatment alleviates behavioural impairments in rats neonatally treated with quinpirole: possible roles of acetylcholine function and neurotrophic factor expression.
The European journal of neuroscience 2004;19(6):1634-42.
2004: Segura Aguilar Juan; Kostrzewa Richard M
Neurotoxins and neurotoxic species implicated in neurodegeneration.
Neurotoxicity research 2004;6(7-8):615-30.
2004: Kostrzewa Richard M; Kostrzewa John P; Nowak Przemyslaw; Kostrzewa Rose A; Brus Ryszard
Dopamine D2 agonist priming in intact and dopamine-lesioned rats.
Neurotoxicity research 2004;6(6):457-62.
2004: Brus Ryszard; Nowak Przemyslaw; Szkilnik Ryszard; Mikolajun Urszula; Kostrzewa Richard M
Serotoninergics attenuate hyperlocomotor activity in rats. Potential new therapeutic strategy for hyperactivity.
Neurotoxicity research 2004;6(4):317-25.
2003: Brus Ryszard; Kostrzewa Richard M; Nowak Przemyslaw; Perry Ken W; Kostrzewa John P
Ontogenetic quinpirole treatments fail to prime for D2 agonist-enhancement of locomotor activity in 6-hydroxydopamine-lesioned rats.
Neurotoxicity research 2003;5(5):329-38.
2003: Kostrzewa Richard M; Segura-Aguilar Juan
Novel mechanisms and approaches in the study of neurodegeneration and neuroprotection. a review.
Neurotoxicity research 2003;5(6):375-83.
2003: Kostrzewa Richard M; Kostrzewa John P; Brus Ryszard
Dopamine receptor supersensitivity: an outcome and index of neurotoxicity.
Neurotoxicity research 2003;5(1-2):111-8.
2002: Brown Russell W; Gass Justin T; Kostrzewa Richard M
Ontogenetic quinpirole treatments produce spatial memory deficits and enhance skilled reaching in adult rats.
Pharmacology, biochemistry, and behavior 2002;72(3):591-600.
2002: Nowak P; Brus R; Oswiecimska J; Sokola A; Kostrzewa R M
7-Nitroindazole enhances amphetamine-evoked dopamine release in rat striatum. an in vivo microdialysis and voltammetric study.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 2002;53(2):251-63.
2002: Kostrzewa R M; Kostrzewa J P; Brus R
Neuroprotective and neurotoxic roles of levodopa (L-DOPA) in neurodegenerative disorders relating to Parkinson's disease.
Amino acids 2002;23(1-3):57-63.
2001: Nowak P; Brus R; Kostrzewa R M
Amphetamine-induced enhancement of neostriatal in vivo microdialysate dopamine content in rats, quinpirole-primed as neonates.
Polish journal of pharmacology 2001;53(4):319-29.
2001: Kostrzewa R M
Neurotoxicity meeting - mechanisms for neurodegenerative disorders. 16-18 March 2001, Pucon, Chile.
IDrugs : the investigational drugs journal 2001;4(6):650-1.
2001: Kostrzewa R M; Brus R; Kostrzewa J P
Insidious dopamine: provocateur or protective agent in Parkinson's disease?
Polish journal of pharmacology 2001;53(2):165-6.
2000: Oswiecimska J; Brus R; Szkilnik R; Nowak P; Kostrzewa R M
7-OH-DPAT, unlike quinpirole, does not prime a yawning response in rats.
Pharmacology, biochemistry, and behavior 2000;67(1):11-5.
2000: Kostrzewa R M
Review of apoptosis vs. necrosis of substantia nigra pars compacta in Parkinson's disease.
Neurotoxicity research 2000;2(2-3):239-50.
2000: Kostrzewa R M; Kostrzewa J P; Brus R
Dopaminergic denervation enhances susceptibility to hydroxyl radicals in rat neostriatum.
Amino acids 2000;19(1):183-99.
1999: Kostrzewa R M
Selective neurotoxins, chemical tools to probe the mind: the first thirty years and beyond.
Neurotoxicity research 1999;1(1):3-25.
1999: Tizabi Y; Copeland R L; Brus R; Kostrzewa R M
Nicotine blocks quinpirole-induced behavior in rats: psychiatric implications.
Psychopharmacology 1999;145(4):433-41.
1999: Kostrzewa R M; Brus R; Perry K W
Interactive modulation by dopamine and serotonin neurons of receptor sensitivity of the alternate neurochemical system.
Polish journal of pharmacology 1999;51(1):39-47.
1998: Kostrzewa R M; Reader T A; Descarries L
Serotonin neural adaptations to ontogenetic loss of dopamine neurons in rat brain.
Journal of neurochemistry 1998;70(3):889-98.
1998: Kostrzewa R M; Brus R
Destruction of catecholamine-containing neurons by 6-hydroxydopa, an endogenous amine oxidase cofactor.
Amino acids 1998;14(1-3):175-9.
1997: Huang N Y; Kostrzewa R M; Li C; Perry K W; Fuller R W
Persistent spontaneous oral dyskinesias in haloperidol-withdrawn rats neonatally lesioned with 6-hydroxydopamine: absence of an association with the Bmax for [3H]raclopride binding to neostriatal homogenates.
The Journal of pharmacology and experimental therapeutics 1997;280(1):268-76.
1997: Brus R; Szkilnik R; Nowak P; Kostrzewa R M
Nitro-l-arginine attenuates SKF 38393-induced oral activity in neonatal 6-hydroxydopamine-lesioned rats.
Acta neurobiologiae experimentalis 1997;57(4):283-7.
1996: Kostrzewa R M; Brus R; Perry K W; Fuller R W
Dopamine and 5-HT receptor sensitivity does not correlate with neostriatal dopamine or 5-HT content.
Acta neurobiologiae experimentalis 1996;56(1):21-8.
1996: Brus R; Szkilnik R; Kostrzewa R M
Nitric oxide (NO) and central dopamine (DA) D3 receptor reactivity to quinpirole in rats.
Acta neurobiologiae experimentalis 1996;56(1):15-9.
1995: Ma S; Lin L; Raghavan R; Cohenour P; Lin P Y; Bennett J; Lewis R J; Enwall E L; Kostrzewa R; Lehr R E
In vivo and in vitro studies on the neurotoxic potential of 6-hydroxydopamine analogs.
Journal of medicinal chemistry 1995;38(20):4087-97.
1995: Plech A; Brus R; Kalbfleisch J H; Kostrzewa R M
Enhanced oral activity responses to intrastriatal SKF 38393 and m-CPP are attenuated by intrastriatal mianserin in neonatal 6-OHDA-lesioned rats.
Psychopharmacology 1995;119(4):466-73.
1995: Brus R; Plech A; Kostrzewa R M
Enhanced quinpirole response in rats lesioned neonatally with 5,7-dihydroxytryptamine.
Pharmacology, biochemistry, and behavior 1995;50(4):649-53.
1995: Brus R; Felinska W; Rykaczewska M; Kostrzewa R M; Szkilnik R; Plech A
Prenatal ethanol diminishes reactivity of presumed dopamine D3 receptors in rats.
Polish journal of pharmacology 1995;47(2):109-14.
1995: Brus R; Kostrzewa R M; Felinska W; Plech A; Szkilnik R; Frydrych J
Ethanol inhibits cadmium accumulation in brains of offspring of pregnant rats that consume cadmium.
Toxicology letters 1995;76(1):57-62.
1995: Kostrzewa R M
Dopamine receptor supersensitivity.
Neuroscience and biobehavioral reviews 1995;19(1):1-17.
1994: Huang N Y; Kostrzewa R M
Persistent oral dyskinesias in haloperidol-withdrawn neonatal 6-hydroxydopamine-lesioned rats.
European journal of pharmacology 1994;271(2-3):433-7.
1994: Gong L; Kostrzewa R M; Li C
Neonatal 6-hydroxydopamine and adult SKF 38393 treatments alter dopamine D1 receptor mRNA levels: absence of other neurochemical associations with the enhanced behavioral responses of lesioned rats.
Journal of neurochemistry 1994;63(4):1282-90.
1994: Huang N Y; Kostrzewa R M
Enhanced oral activity response to A77636 in neonatal 6-hydroxydopamine-lesioned rats.
European journal of pharmacology 1994;253(1-2):163-6.
1994: Brus R; Kostrzewa R M; Perry K W; Fuller R W
Supersensitization of the oral response to SKF 38393 in neonatal 6-hydroxydopamine-lesioned rats is eliminated by neonatal 5,7-dihydroxytryptamine treatment.
The Journal of pharmacology and experimental therapeutics 1994;268(1):231-7.
1994: Kostrzewa R M; Brus R; Kalbfleisch J H; Perry K W; Fuller R W
Proposed animal model of attention deficit hyperactivity disorder.
Brain research bulletin 1994;34(2):161-7.
1993: Gong L; Kostrzewa R M; Perry K W; Fuller R W
Dose-related effects of a neonatal 6-OHDA lesion on SKF 38393- and m-chlorophenylpiperazine-induced oral activity responses of rats.
Brain research. Developmental brain research 1993;76(2):233-8.
1993: Kostrzewa R M; Brus R; Perry K W; Fuller R W
Age-dependence of a 6-hydroxydopamine lesion on SKF 38393- and m-chlorophenylpiperazine-induced oral activity responses of rats.
Brain research. Developmental brain research 1993;76(1):87-93.
1993: Gong L; Kostrzewa R M; Brus R; Fuller R W; Perry K W
Ontogenetic SKF 38393 treatments sensitize dopamine D1 receptors in neonatal 6-OHDA-lesioned rats.
Brain research. Developmental brain research 1993;76(1):59-65.
1993: Gong L; Kostrzewa R M; Kalbfleisch J H
MIF-1 fails to modify agonist-induced oral activity in neonatal 6-OHDA-treated rats.
Peptides 1993;14(6):1159-64.
1993: Kostrzewa R M; Guo J; Kostrzewa F P
Ontogenetic quinpirole treatment induces vertical jumping activity in rats.
European journal of pharmacology 1993;239(1-3):183-7.
1993: Kostrzewa R M; Neely D
Enhanced pilocarpine-induced oral activity responses in neonatal 6-OHDA treated rats.
Pharmacology, biochemistry, and behavior 1993;45(3):737-40.
1993: Kostrzewa R M; Brus R; Rykaczewska M; Plech A
Low-dose quinpirole ontogenically sensitizes to quinpirole-induced yawning in rats.
Pharmacology, biochemistry, and behavior 1993;44(2):487-9.
1993: Kostrzewa R M; Gong L; Brus R
Serotonin (5-HT) systems mediate dopamine (DA) receptor supersensitivity.
Acta neurobiologiae experimentalis 1993;53(1):31-41.
1993: Kostrzewa R M; Kastin A J
Tyr-MIF-1 attenuates development of tolerance to spiperone-induced catalepsy in rats.
Brain research bulletin 1993;31(6):707-12.
1992: Gong L; Kostrzewa R M; Fuller R W; Perry K W
Supersensitization of the oral response to SKF 38393 in neonatal 6-OHDA-lesioned rats is mediated through a serotonin system.
The Journal of pharmacology and experimental therapeutics 1992;261(3):1000-7.
1992: Gong L; Kostrzewa R M
Supersensitized oral responses to a serotonin agonist in neonatal 6-OHDA-treated rats.
Pharmacology, biochemistry, and behavior 1992;41(3):621-3.
1992: Kostrzewa R M; Brus R; Coy D H; Criswell H; Coogan P S; Kastin A J
D-Ala2,F5Phe4-dynorphin amide, an opiate with analgesic and toxic properties.
Polish journal of pharmacology and pharmacy 1992;44(2):109-20.
1991: Kostrzewa R M; Brus R; Kalbfleisch J
Ontogenetic homologous sensitization to the antinociceptive action of quinpirole in rats.
European journal of pharmacology 1991;209(3):157-61.
1991: Hamdi A; Kostrzewa R M
Ontogenic homologous supersensitization of dopamine D1 receptors.
European journal of pharmacology 1991;203(1):115-20.
1991: Kostrzewa R M; Gong L
Supersensitized D1 receptors mediate enhanced oral activity after neonatal 6-OHDA.
Pharmacology, biochemistry, and behavior 1991;39(3):677-82.
1991: Kostrzewa R M; Brus R
Ontogenic homologous supersensitization of quinpirole-induced yawning in rats.
Pharmacology, biochemistry, and behavior 1991;39(2):517-9.
1991: Kostrzewa R M; Hamdi A
Potentiation of spiperone-induced oral activity in rats after neonatal 6-hydroxydopamine.
Pharmacology, biochemistry, and behavior 1991;38(1):215-8.
1991: Kostrzewa R M; Brus R
Is dopamine-agonist induced yawning behavior a D3 mediated event?
Life sciences 1991;48(26):PL129.
1989: Kostrzewa R M; Saleh M I
Attenuation of SCH 23390-induced alteration of striatal dopamine D1 receptor ontogeny by prolyl-leucyl-glycinamide in the rat.
Neuropharmacology 1989;28(8):805-10.
1989: Kostrzewa R M; White T G; Zadina J E; Kastin A J
MIF-1 attenuates apomorphine stereotypies in adult rats after neonatal 6-hydroxydopamine.
European journal of pharmacology 1989;163(1):33-42.
1989: Kostrzewa R M; Saleh M I
Impaired ontogeny of striatal dopamine D1 and D2 binding sites after postnatal treatment of rats with SCH-23390 and spiroperidol.
Brain research. Developmental brain research 1989;45(1):95-101.
1989: Saleh M I; Kostrzewa R M
MIF-1 attenuates spiroperidol alteration of striatal dopamine D2 receptor ontogeny.
Peptides 1989;10(1):35-9.
1988: Saleh M I; Kostrzewa R M
Impaired striatal dopamine receptor development: differential D-1 regulation in adults.
European journal of pharmacology 1988;154(3):305-11.
1988: Kostrzewa R M; Hardin J C; Jacobowitz D M
Destruction of cells in the midportion of the locus coeruleus by a dorsal bundle lesion in neonatal rats.
Brain research 1988;442(2):321-8.
1986: Kostrzewa R M; Harston C T
Altered histofluorescent pattern of noradrenergic innervation of the cerebellum of the mutant mouse Purkinje cell degeneration.
Neuroscience 1986;18(4):809-15.
1986: Klisans-Fuenmayor D; Harston C T; Kostrzewa R M
Alterations in noradrenergic innervation of the brain following dorsal bundle lesions in neonatal rats.
Brain research bulletin 1986;16(1):47-54.
1984: Kostrzewa R M; Klisans-Fuenmayor D
Development of an opioid-specific action of morphine in modifying recovery of neonatally-damaged noradrenergic fibers in rat brain.
Research communications in chemical pathology and pharmacology 1984;46(1):3-11.
1982: Kostrzewa R M; Harston C T; Fukushima H; Brus R
Noradrenergic fiber sprouting in the cerebellum.
Brain research bulletin 1982;9(1-6):509-17.
1982: Harston C T; Clark M B; Hardin J C; Kostrzewa R M
Developmental localization of noradrenergic innervation to the rat cerebellum following neonatal 6-hydroxydopa and morphine treatment.
Developmental neuroscience 1982;5(2-3):252-62.
1981: Harston C T; Clark M B; Hardin J C; Kostrzewa R M
Opiate-enhanced toxicity and noradrenergic sprouting in rats treated with 6-hydroxydopa.
European journal of pharmacology 1981;71(4):365-73.
1980: Kostrzewa R M; Fukushima H; Morrow A; Cohenour P; Hsi T; Lehr R E; Blank C L
alpha-Methyl-6-aminodopamine: depletion of catecholamines in mouse brain and peripheral tissues.
Life sciences 1980;27(23):2245-50.
1980: Harston C T; Morrow A; Kostrzewa R M
Enhancement of sprouting and putative regeneration of central noradrenergic fibers by morphine.
Brain research bulletin 1980;5(4):421-4.

Sign-in to see more